COMMONWEALTH EQUITY SERVICES, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$8,000
-20.0%
11,0000.0%0.00%
Q2 2022$10,0000.0%11,0000.0%0.00%
Q1 2022$10,0000.0%11,0000.0%0.00%
Q4 2021$10,0000.0%11,0000.0%0.00%
Q3 2021$10,0000.0%11,0000.0%0.00%
Q2 2021$10,0000.0%11,0000.0%0.00%
Q1 2021$10,0000.0%11,0000.0%0.00%
Q4 2020$10,0000.0%11,0000.0%0.00%
Q3 2020$10,0000.0%11,0000.0%0.00%
Q2 2020$10,0000.0%11,0000.0%0.00%
Q1 2020$10,0000.0%11,0000.0%0.00%
Q4 2019$10,000
+11.1%
11,0000.0%0.00%
Q3 2019$9,000
-10.0%
11,0000.0%0.00%
Q2 2019$10,0000.0%11,0000.0%0.00%
Q1 2019$10,000
+11.1%
11,0000.0%0.00%
Q4 2018$9,000
-10.0%
11,0000.0%0.00%
Q3 2018$10,000
-37.5%
11,000
-35.3%
0.00%
Q2 2018$16,000
+14.3%
17,0000.0%0.00%
Q1 2018$14,000
-6.7%
17,0000.0%0.00%
Q4 2017$15,00017,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2020
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 68,443,000$68,785,00010.97%
PIPER SANDLER & CO. 12,550,000$12,425,0008.95%
Radcliffe Capital Management, L.P. 100,783,000$100,279,0006.28%
INCOME RESEARCH & MANAGEMENT 14,775,000$14,701,0005.39%
PenderFund Capital Management Ltd. 4,000,000$5,123,0001.30%
Bracebridge Capital, LLC 5,500,000$5,390,0000.82%
Western Asset Management Company, LLC 9,000,000$8,916,0000.57%
WESTWOOD HOLDINGS GROUP INC 43,125,000$42,856,0000.49%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,050,000$1,045,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,675,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders